Total Payments
$10,140
2024 Payments
$2,266
Companies
46
Transactions
566
Medicare Patients
2,702
Medicare Billing
$567,901
Payment Breakdown by Category
Food & Beverage$8,812 (86.9%)
Education$917.00 (9.0%)
Travel$338.00 (3.3%)
Other$73.42 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,812 | 550 | 86.9% |
| Education | $917.00 | 10 | 9.0% |
| Travel and Lodging | $338.00 | 1 | 3.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $73.42 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $1,511 | 47 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,387 | 49 | $0 (2024) |
| ABBVIE INC. | $1,254 | 130 | $0 (2024) |
| Biogen, Inc. | $692.32 | 40 | $0 (2022) |
| Cyberonics, Inc. | $538.31 | 4 | $0 (2017) |
| UCB, Inc. | $467.45 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $388.08 | 30 | $0 (2024) |
| PFIZER INC. | $358.15 | 26 | $0 (2024) |
| Lilly USA, LLC | $336.29 | 22 | $0 (2024) |
| Amgen Inc. | $297.93 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,266 | 114 | EMD Serono, Inc. ($903.30) |
| 2023 | $1,125 | 58 | EMD Serono, Inc. ($425.75) |
| 2022 | $949.61 | 78 | ABBVIE INC. ($323.44) |
| 2021 | $1,114 | 65 | Teva Pharmaceuticals USA, Inc. ($256.00) |
| 2020 | $475.01 | 26 | Teva Pharmaceuticals USA, Inc. ($109.72) |
| 2019 | $1,177 | 66 | Amgen Inc. ($227.09) |
| 2018 | $1,290 | 88 | Teva Pharmaceuticals USA, Inc. ($333.24) |
| 2017 | $1,743 | 71 | Cyberonics, Inc. ($538.31) |
All Payment Transactions
566 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $124.03 | General |
| Category: Neurology | ||||||
| 12/09/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.28 | General |
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: PAIN | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/22/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.87 | General |
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Neurology | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/08/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $70.32 | General |
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: PAIN | ||||||
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Obesity | ||||||
| 10/29/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.78 | General |
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.21 | General |
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: PAIN | ||||||
| 10/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $36.13 | General |
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: PAIN | ||||||
| 10/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Central Nervous System | ||||||
| 09/26/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 565 | 17,191 | $369,863 | $140,153 |
| 2022 | 13 | 631 | 16,124 | $363,812 | $139,871 |
| 2021 | 17 | 857 | 20,286 | $451,267 | $178,322 |
| 2020 | 13 | 649 | 12,576 | $291,429 | $109,556 |
Total Patients
2,702
Total Services
66,177
Medicare Billing
$567,901
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 28 | 16,400 | $180,400 | $78,650 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 266 | 335 | $68,675 | $26,114 | 38.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 28 | 87 | $37,410 | $9,796 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 73 | 77 | $21,098 | $9,071 | 43.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 63 | 63 | $24,759 | $8,528 | 34.4% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 18 | 53 | $22,553 | $4,060 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 55 | $7,645 | $3,313 | 43.3% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 16 | 29 | $3,799 | $348.00 | 9.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 16 | 40 | $3,160 | $240.25 | 7.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 52 | $364.00 | $33.20 | 9.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 24 | 15,200 | $167,200 | $73,632 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 286 | $58,630 | $23,956 | 40.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 89 | 89 | $34,977 | $12,200 | 34.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 26 | 86 | $36,980 | $9,957 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 63 | 67 | $18,358 | $8,625 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 129 | $17,931 | $6,037 | 33.7% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 18 | 48 | $20,079 | $3,517 | 17.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 11 | 19 | $1,482 | $493.38 | 33.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 12 | $1,212 | $481.98 | 39.8% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2022 | 17 | 35 | $4,585 | $457.02 | 10.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $390.00 | $354.07 | 90.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 17 | 126 | $882.00 | $117.22 | 13.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 11 | 14 | $1,106 | $42.17 | 3.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 33 | 19,200 | $211,200 | $92,817 | 43.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 214 | 270 | $55,350 | $22,467 | 40.6% |
About Dr. Jeanie Mccormack, DO
Dr. Jeanie Mccormack, DO is a Neurology healthcare provider based in Owensboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1508043274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeanie Mccormack, DO has received a total of $10,140 in payments from pharmaceutical and medical device companies, with $2,266 received in 2024. These payments were reported across 566 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($8,812).
As a Medicare-enrolled provider, Mccormack has provided services to 2,702 Medicare beneficiaries, totaling 66,177 services with total Medicare billing of $567,901. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Owensboro, KY
- Active Since 01/24/2008
- Last Updated 09/21/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1508043274
Products in Payments
- VNS Therapy (Device) $708.72
- UBRELVY (Drug) $538.08
- TECFIDERA (Drug) $505.12
- NURTEC ODT (Drug) $445.56
- BOTOX (Biological) $442.76
- Briviact (Drug) $336.49
- EMGALITY (Drug) $321.68
- QULIPTA (Drug) $320.57
- Aimovig (Biological) $285.14
- AJOVY (Biological) $254.27
- Mavenclad (Drug) $243.85
- APTIOM (Drug) $224.17
- MAVENCLAD (Drug) $220.95
- Gamunex-C (Biological) $203.00
- KESIMPTA (Drug) $200.17
- NUPLAZID (Drug) $196.61
- INGREZZA (Drug) $191.76
- AJOVY (Drug) $164.78
- OCREVUS (Biological) $160.62
- BOTOX THERAPEUTIC (Biological) $140.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Owensboro
James Lamb, Md, MD
Neurology — Payments: $15,054
Neurology $15,054
Dr. Clare Braun Hashemi, M.d, M.D
Neurology — Payments: $5,586
Neurology $5,586
Kortney Lacombe, Do, DO
Neurology — Payments: $5,065
Neurology $5,065
Satish Shah, Md, MD
Neurology — Payments: $2,513
Neurology $2,513
Anna Ehret, M.d, M.D
Neurology — Payments: $2,485
Neurology $2,485
Randy Cox, Md, MD
Neurology — Payments: $1,824
Neurology $1,824